| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,810 | 7,399 | 7,007 | 7,728 | | Cost of Revenue | 3,882 | 3,598 | 3,665 | 5,011 | | | Gross Profit | 3,928 | 3,801 | 3,342 | 2,717 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,491 | 835 | 879 | 905 | | Non Recurring |
-
|
-
|
-
| 18,956 | | Others | 4,501 | 4,448 | 4,717 | 10,987 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,064) | (1,482) | (2,254) | (28,131) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,116 | (8,385) | 7,414 | 42,800 | | Earnings Before Interest And Taxes | (8,039) | (9,867) | 5,160 | 14,669 | | Interest Expense | (4,803) | 2,356 | 2,447 | 3,142 | | Income Before Tax | (3,236) | (12,223) | 2,713 | 11,527 | | Income Tax Expense | (1,218) | (4,209) | 923 | 2,952 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,018) | (8,014) | 1,790 | 8,575 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,018) | (8,014) | 1,790 | 8,575 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,018) | ($8,014) | $1,790 | $8,575 |
|
0.51% Nasdaq 
0.60 (0.83%) 
Income Statement
